Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orexin and Tau Pathology in Cognitively Normal Elderly (A New Prevention Strategy for Alzheimer's Disease)

NCT03053908 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03053908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orexin and Tau Pathology in Cognitively Normal Elderly (A New Prevention Strategy for Alzheimer's Disease)
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
March 27, 2018
Completion date
May 13, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, elderly